Combining hypoxia-activated prodrugs and radiotherapy in silico: Impact of treatment scheduling and the intra-tumoural oxygen landscape

Sara Hamis, Mohammad Kohandel, Ludwig J. Dubois, Ala Yaromina, Philippe Lambin, Gibin G. Powathil*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number1008041
Number of pages27
JournalPLoS Computational Biology
Volume16
Issue number8
DOIs
Publication statusPublished - Aug 2020

Keywords

  • CELL-CYCLE
  • TH-302
  • COMBINATION
  • RADIATION
  • PHARMACOKINETICS
  • THERAPY
  • EVOFOSFAMIDE
  • CHEMOTHERAPY
  • REGIMENS
  • POTENT

Cite this